Paolo Marchi

450 total citations
15 papers, 333 citations indexed

About

Paolo Marchi is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, Paolo Marchi has authored 15 papers receiving a total of 333 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Cellular and Molecular Neuroscience and 3 papers in Oncology. Recurrent topics in Paolo Marchi's work include Mitochondrial Function and Pathology (3 papers), Hereditary Neurological Disorders (3 papers) and Virus-based gene therapy research (2 papers). Paolo Marchi is often cited by papers focused on Mitochondrial Function and Pathology (3 papers), Hereditary Neurological Disorders (3 papers) and Virus-based gene therapy research (2 papers). Paolo Marchi collaborates with scholars based in United Kingdom, Italy and Canada. Paolo Marchi's co-authors include Simonetta Sipione, Alba Di Pardo, Mimoun Azzouz, Susanne Lingrell, Lara Marrone, Vittorio Maglione, Jelena Kolic, Patrick E. MacDonald, Xiao-Qing Dai and Luisella Alberti and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Journal of Neuroscience.

In The Last Decade

Paolo Marchi

13 papers receiving 324 citations

Peers

Countries citing papers authored by Paolo Marchi

Since Specialization

Citations

This map shows the geographic impact of Paolo Marchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paolo Marchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paolo Marchi more than expected).

Fields of papers citing papers by Paolo Marchi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paolo Marchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paolo Marchi. The network helps show where Paolo Marchi may publish in the future.

Co-authorship network of co-authors of Paolo Marchi

This figure shows the co-authorship network connecting the top 25 collaborators of Paolo Marchi. A scholar is included among the top collaborators of Paolo Marchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paolo Marchi. Paolo Marchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Description of Catenibacterium mitsuokai subsp. tridentinum subsp. nov., an anaerobic bacterium isolated from human faeces, and emended description of C. mitsuokai 2025 ·INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY ·Liviana Ricci, Marta Selma‐Royo, Davide Golzato, Charlotte Servais, (unknown), Paolo Marchi, Michal Punčochář, (unknown), Mar Garcia‐Aloy, Federica Armanini, (unknown), Francesco Asnicar, Federica Pinto, Graziano Guella, Sabrina Tamburini, Nicola Segata	0
2	Ap4b1-knockout mouse model of hereditary spastic paraplegia type 47 displays motor dysfunction, aberrant brain morphology and ATG9A mislocalization 2022 ·Brain Communications ·(unknown), (unknown), Paolo Marchi, Christopher P Webster, (unknown), Evangelia Karyka, (unknown), Ian Coldicott, (unknown), Mimoun Azzouz	9
3	SMN-deficient cells exhibit increased ribosomal DNA damage 2022 ·Life Science Alliance ·Evangelia Karyka, (unknown), Christopher P Webster, Paolo Marchi, (unknown), Vinay K. Godena, Lara Marrone, (unknown), Swagat Ray, Ke Ning, (unknown), Guillaume M. Hautbergue, Sherif F. El‐Khamisy, Mimoun Azzouz	9
4	SPG15 protein deficits are at the crossroads between lysosomal abnormalities, altered lipid metabolism and synaptic dysfunction 2022 ·Human Molecular Genetics ·Lara Marrone, Paolo Marchi, Christopher P Webster, (unknown), Ian Coldicott, Steven Reynolds, (unknown), (unknown), Adrian Higginbottom, Mukhran Khundadze, Pamela J. Shaw, Christian A. Hübner, Matthew R. Livesey, Mimoun Azzouz	10
5	Circumventing the packaging limit of AAV-mediated gene replacement therapy for neurological disorders 2021 ·Expert Opinion on Biological Therapy ·Lara Marrone, Paolo Marchi, Mimoun Azzouz	30
6	Delivery of therapeutic AAV9 vectors via cisterna magna to treat neurological disorders 2021 ·Trends in Molecular Medicine ·Paolo Marchi, Lara Marrone, Mimoun Azzouz	15
7	Patient Preference and Physician Perceptions of Patient Preference for Oral Pharmaceutical Formulations: Results from a Real-Life Survey 2018 ·Inflammatory Intestinal Diseases ·(unknown), Paolo Marchi, (unknown), (unknown), (unknown), (unknown)	15
8	Randomised phase 3 open-label trial of first-line treatment with gemcitabine in association with docetaxel or paclitaxel in women with metastatic breast cancer: a comparison of different schedules and treatments 2013 ·BMC Cancer ·Lucia Del Mastro, Alessandra Fabi, Mauro Mansutti, Michelino De Laurentiis, Antonio Durando, Domenico Franco Merlo, Paolo Bruzzi, Ignazia La Torre, (unknown), Gbenga Kazeem, Paolo Marchi, (unknown), Marco Venturini, Sabino De Placido, Francesco Cognetti	16
9	SAT0353 Back pain and quality of life: 18- and 24-month final results from the italian study on severe osteoporosis (ISSO) 2012 ·Annals of the Rheumatic Diseases ·Francesco Bertoldo, Ombretta Di Munno, L. Pietrogrande, R. Del Fiacco, Helmut Petto, Paolo Marchi, (unknown)	1
10	Phase III trial of first-line treatment with gemcitabine plus docetaxel versus gemcitabine plus paclitaxel in women with metastatic breast cancer (MBC): A comparison of different schedules and treatment. 2012 ·Journal of Clinical Oncology ·Lucia Del Mastro, Alessandra Fabi, Mauro Mansutti, Michelino De Laurentiis, Antonio Durando, Giuseppe Colantuoni, Alberto Zaniboni, Sandro Barni, Domenico Franco Merlo, Paolo Bruzzi, Ignazia La Torre, (unknown), Gbenga Kazeem, Paolo Marchi, (unknown), Marco Venturini, Sabino De Placido, F. Cognetti	2
11	The Right to Health of Nomadic Groups 2010 ·Nomadic Peoples ·Paolo Marchi	5
12	Making rights more relevant for health professionals 2010 ·The Lancet ·Asha George, Mickey Chopra, (unknown), Paolo Marchi	7
13	Mutant Huntingtin induces activation of the Bcl-2/adenovirus E1B 19-kDa interacting protein (BNip3) 2010 ·Cell Death and Disease ·Jenny Sassone, (unknown), Paolo Marchi, (unknown), Luisella Alberti, Alba Di Pardo, Renata Zippel, Simonetta Sipione, Vincenzo Silani, Andrea Ciammola	26
14	Impaired Ganglioside Metabolism in Huntington's Disease and Neuroprotective Role of GM1 2010 ·Journal of Neuroscience ·Vittorio Maglione, Paolo Marchi, Alba Di Pardo, Susanne Lingrell, (unknown), (unknown), Simonetta Sipione	113
15	SUMOylation regulates Kv2.1 and modulates pancreatic β-cell excitability 2009 ·Journal of Cell Science ·Xiao-Qing Dai, Jelena Kolic, Paolo Marchi, Simonetta Sipione, Patrick E. MacDonald	75

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact